NEURAXIS, INC. Increase (Decrease) in Accounts Payable
NEURAXIS, INC. (NRXS) reported Increase (Decrease) in Accounts Payable of $652.22 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- NEURAXIS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $486.29K.
- NEURAXIS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $165.93K.
- NEURAXIS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$747.03K.
- NEURAXIS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $421.88K.
- NEURAXIS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$457.58K.
- NEURAXIS, INC. increase (decrease) in accounts payable for fiscal 2024 was -$607.27K.
- NEURAXIS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$387.90K, a 135.00% decline from fiscal 2022.
- NEURAXIS, INC. increase (decrease) in accounts payable for fiscal 2022 was $1.11M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $486.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $652.22K 10-Q · filed 2026-08-11 | -$94.81K derived: sum of 3 quarters · filed 2026-08-11 | $327.07K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $165.93K 10-Q · filed 2026-05-12 | -$581.10K derived: sum of 2 quarters · filed 2026-05-12 | -$159.22K derived: sum of 3 quarters · filed 2026-05-12 | -$229.72K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$747.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$325.15K derived: sum of 2 quarters · filed 2026-03-19 | -$395.65K derived: sum of 3 quarters · filed 2026-08-11 | -$457.58K 10-K · filed 2026-03-19 |
| 2025-09-30 | $421.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $351.38K derived: sum of 2 quarters · filed 2026-08-11 | $289.45K 10-Q · filed 2025-11-10 | -$75.71K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$70.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$132.43K 10-Q · filed 2026-08-11 | -$497.59K derived: sum of 3 quarters · filed 2026-08-11 | -$653.80K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$61.93K 10-Q · filed 2026-05-12 | -$427.09K derived: sum of 2 quarters · filed 2026-05-12 | -$583.30K derived: sum of 3 quarters · filed 2026-05-12 | -$702.02K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | -$365.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | -$521.37K derived: sum of 2 quarters · filed 2026-03-19 | -$640.09K derived: sum of 3 quarters · filed 2026-03-19 | -$607.27K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$156.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$274.93K derived: sum of 2 quarters · filed 2025-11-10 | -$242.11K 10-Q · filed 2025-11-10 | $395.46K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | -$118.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$85.90K 10-Q · filed 2025-08-12 | $551.67K derived: sum of 3 quarters · filed 2025-08-12 | -$1.32M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $32.82K 10-Q · filed 2025-05-12 | $670.39K derived: sum of 2 quarters · filed 2025-05-12 | -$1.20M derived: sum of 3 quarters · filed 2025-05-12 | -$823.75K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $637.57K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$1.23M derived: sum of 2 quarters · filed 2025-03-20 | -$856.57K derived: sum of 3 quarters · filed 2025-03-20 | -$387.90K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$1.49M derived: sum of 2 quarters · filed 2024-11-12 | -$1.03M 10-Q · filed 2024-11-12 | -$276.79K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $377.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $846.00K 10-Q · filed 2024-08-09 | $1.59M derived: sum of 3 quarters · filed 2024-08-09 | $2.07M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $468.67K 10-Q · filed 2024-05-20 | $1.22M derived: sum of 2 quarters · filed 2024-05-20 | $1.70M derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | $748.67K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $1.23M derived: sum of 2 quarters · filed 2024-04-16 | $1.11M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $478.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $359.65K 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | -$118.56K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |